Abstract
Antibodies against gangliosides and neutral glycosphingolipids (GSLs) have been reported previously in the sera of patients with multiple sclerosis (MS)1-5 and systemic lupus erythematosus (SLE). The specificity of these antibodies has not been examined in detail, and in studies in which a liposome lysis assay was used the lytic factor in serum was not clearly identified as an immunoglobulin. The long term objectives of this study are to characterize the specificity of anti-GSL antibodies, to determine their incidence in immunological and non-immunological diseases that affect the nervous system, and to examine the temporal fluctuation of antibody levels in relation to disease activity. In this report we present our initial findings on the incidence and specificity of anti-GSL antibodies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M. Yokoyama, E. G. Trams, and R. O. Brady, Sphingolipid antibodies in sera of animals and patients with central nervous system lesions, Proc. Soc. Exp. Biol. Med. 111:350 (1962).
H. E. Hirsch and M. E. Parks, Serological reactions against glycolipid-sensitised liposomes in multiple sclerosis, Nature 264:785 (1976).
B. Ryberg, Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy, J. Neurol. Sci. 38:357 (1978).
B. R. Mullin, A. J. Montanaro, J. D. Reid, and R. N. Nishimura, Interaction of multiple sclerosis serum with liposomes containing ganglioside GM1, Ann, Neurol. 7:587 (1979).
R. Arnon, E. Crisp, R. Kelley, G. W. Ellison, L. W. Myers, and W. W. Tourtellotte, Anti-ganglioside antibodies in multiple sclerosis, J. Neurol. Sci. 46:179 (1980).
T. Hirano, H. Hasimoto, Y. Shiokawa, M. Iwamori, Y. Nagai, M. Kasai, Y. Ochiai, and K. Okumura, Anti-glycolipid autoantibody detected in the sera from systemic lupus erythematosus patients, J. Clin. Invest. 66:1437 (1980).
M. Naiki, D. M. Marcus, and R. Ledeen, Properties of antisera to ganglioside GM1 and asialo GM1, J. Immunol. 113:84 (1974).
S. K. Kundu, D. M. Marcus, and R. W. Veh, Preparation and properties of antibodies to GD3 and GM1 gangliosides, J. Neurochem. 34:184 (1980).
M. M. Rapport, L. Graf, Y. L. Huang, W. Brunner, and R. K. Yu, Antibodies to total brain gangliosides: Titer and specificity of antisera, in: “Structure and Function of Gangliosides”, L. Svennerholm, P. Mandel, H. Dreyfus, and P. F. Urban, eds., Plenum Press, New York (1980).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Endo, T., Scott, D.D., Stewart, S.S., Kundu, S.K., Marcus, D.M. (1984). Antibodies to Glycosphingolipids in Patients with Multiple Sclerosis and SLE. In: Ledeen, R.W., Yu, R.K., Rapport, M.M., Suzuki, K. (eds) Ganglioside Structure, Function, and Biomedical Potential. Advances in Experimental Medicine and Biology, vol 174. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1200-0_38
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1200-0_38
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1202-4
Online ISBN: 978-1-4684-1200-0
eBook Packages: Springer Book Archive